SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-21-244841
Filing Date
2021-08-12
Accepted
2021-08-12 17:00:36
Documents
2
Group Members
NAN FUNG GROUP HOLDINGS LTDNAN FUNG LIFE SCIENCES HOLDINGS LTDNF INVESTMENT HOLDINGS LTDPIVOTAL BIOVENTURE PARTNERS FUND I G.P., L.P.PIVOTAL BIOVENTURE PARTNERS FUND I U.G.P. LTD.PIVOTAL LIFE SCIENCES HOLDINGS LTDPIVOTAL PARTNERS LTD

Document Format Files

Seq Description Document Type Size
1 SC 13D d57170dsc13d.htm SC 13D 154944
2 EX-99.1 d57170dex991.htm EX-99.1 14671
  Complete submission text file 0001193125-21-244841.txt   171654
Mailing Address 501 SECOND STREET, SUITE 200 SAN FRANCISCO CA 94107
Business Address 501 SECOND STREET, SUITE 200 SAN FRANCISCO CA 94107 (345) 949 1040
Pivotal bioVenture Partners Fund I, L.P. (Filed by) CIK: 0001695076 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 0331
Type: SC 13D

Mailing Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510
Business Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510 203- 859-3820
Rallybio Corp (Subject) CIK: 0001739410 (see all company filings)

IRS No.: 851083789 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92742 | Film No.: 211168495
SIC: 2834 Pharmaceutical Preparations